P-PSMA-101 Generates Long-Lasting Response to Prostate Cancer, Mouse Study Shows

P-PSMA-101 Generates Long-Lasting Response to Prostate Cancer, Mouse Study Shows
Poseida Therapeutics’ P-PSMA-101 eliminated prostate cancer in all mice that were treated in a study and prevented it from returning in two-thirds, researchers reported. The long-lasting nature of the therapy surfaced in the finding that two out of three mice remained cancer-free at the end of the 42-day study, the team said. P-PSMA-101 is a CAR

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *